Photodynamic Treatment in the Management of Residual Biofilm - a Crossover Study
Launched by KOITE HEALTH OY · Mar 4, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new home-use device designed to help reduce plaque and bacteria on teeth more effectively than traditional cleaning methods, like brushing and flossing. The device uses dual light technology to target biofilm, which is a sticky layer of bacteria that can form on teeth. The researchers want to see if using this device at home can help keep your teeth cleaner and healthier compared to just mechanical cleaning.
To participate in this study, you should be a healthy adult aged between 65 and 74 years old, and you need to be able to take care of your own oral hygiene. If you have gum disease or have trouble maintaining regular oral care, you might not be eligible. If you join the trial, you'll be asked to use the device and then share your experiences, helping researchers understand its effectiveness. This study could lead to better ways for everyone to maintain oral health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signed informed consent voluntarily
- • Good general health
- Exclusion Criteria:
- • Periodontitis
- • Inability to perform regular oral self-care
About Koite Health Oy
Koite Health Oy is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. Based in Finland, the company specializes in designing and managing clinical trials that focus on cutting-edge therapies and medical technologies. With a commitment to improving patient outcomes, Koite Health Oy leverages a team of experienced professionals and robust methodologies to ensure the highest standards of quality and compliance throughout the research process. By fostering collaborations with healthcare providers and stakeholders, Koite Health Oy aims to bring transformative solutions to the market, enhancing the efficacy and accessibility of treatments for various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, , Finland
Patients applied
Trial Officials
Mikko Kylmänen
Study Director
Koite Health Oy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported